These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 30227359)
1. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study. Muteshi C; Child T; Ohuma E; Fatum M Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359 [TBL] [Abstract][Full Text] [Related]
2. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response. Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898 [TBL] [Abstract][Full Text] [Related]
3. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts. Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413 [TBL] [Abstract][Full Text] [Related]
6. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Creux H; Monnier P; Son WY; Tulandi T; Buckett W Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up. Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910 [TBL] [Abstract][Full Text] [Related]
8. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329 [TBL] [Abstract][Full Text] [Related]
9. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response. Alvarez RM; Ramanathan P Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358 [TBL] [Abstract][Full Text] [Related]
10. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre. Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262 [TBL] [Abstract][Full Text] [Related]
11. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139 [TBL] [Abstract][Full Text] [Related]
13. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation. İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878 [TBL] [Abstract][Full Text] [Related]
16. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Talaulikar VS; Conway GS; Pimblett A; Davies MC Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940 [TBL] [Abstract][Full Text] [Related]
18. In vitro maturation of human immature oocytes for fertility preservation. Chian RC; Uzelac PS; Nargund G Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515 [TBL] [Abstract][Full Text] [Related]
19. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients. Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606 [TBL] [Abstract][Full Text] [Related]
20. The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis. Turan V; Quinn MM; Dayioglu N; Rosen MP; Oktay K Fertil Steril; 2018 Dec; 110(7):1347-1355. PubMed ID: 30503134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]